INGRID AVILA: Open Payments
NPI 1649871385 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 100 payments from 18 companies in 2025. Trend: 2023 $1,457 · 2024 $1,731 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK INC. | 13 | $209 |
| Novartis Pharmaceuticals Corporation | 15 | $185 |
| PFIZER INC. | 9 | $179 |
| Amgen Inc. | 14 | $167 |
| Novo Nordisk Inc | 7 | $165 |
| Esperion Therapeutics, Inc. | 8 | $141 |
| CVRx, Inc. | 6 | $138 |
| Lilly USA, LLC | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| Boston Scientific Corporation | 3 | $75 |
Products named: LEQVIO, REPATHA, VYNDAQEL, NEXLETOL, Barostim Neo System, Wegovy, WATCHMAN FLX, VERQUVO.
Industry payments across FL — which companies pay providers there.
